Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 8/12/2019
SIETES contiene 92850 citas

 1 a 20 de 65 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Marciniak TA, Cherepanov V, Golukhova I, Hyun Kim M, Serebruany V. Drug discontinuation and follow-up rates in oral antithrombotic trials. JAMA Intern Med 2016;176:11 de enero. [Ref.ID 99961]
2.Tiene citas relacionadas Cita con resumen
Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ 2013;347:11. [Ref.ID 96346]
3.Tiene citas relacionadas Cita con resumen
Hirschl MM. Smoking status and the effects of antiplatelet drugs. BMJ 2013;347:10. [Ref.ID 96345]
4.Tiene citas relacionadas
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran DJ, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzylio W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013;382:605-13. [Ref.ID 96025]
5.Tiene citas relacionadas
Swaminathan RV, Feldman DN. TRILOGY ACS: prasugrel of benefit only after angiography?. Lancet 2013;382:580-2. [Ref.ID 96024]
6.Tiene citas relacionadas Cita con resumen
Doshi P, Dickersin K, Healy D, Vedula SS, Jefferson T. Restoring invisible and abandoned trials: a call for people to publish the findings. BMJ 2013;346:23-6. [Ref.ID 95962]
7.Tiene citas relacionadas
Schroll JB, Bero L, Gotzsche PC. Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ 2013;346:12. [Ref.ID 95960]
8.Tiene citas relacionadas Cita con resumen
Loder E, Godlee F, Barbour V, Winker M. Restoring the integrity of the clinical trial evidence base. BMJ 2013;346:7. [Ref.ID 95959]
9. Cita con resumen
Gurbel PA, Nolin TD, Tantry US. Clopidogrel efficacy and cigarette smoking status. JAMA 2012;307:2495-6. [Ref.ID 93316]
10.Tiene citas relacionadas Cita con resumen
Lee M, Ovbiagele B. Vascular events after stroke: terutroban fails to PERFORM. Lancet 2011;377:1980-2. [Ref.ID 91298]
11.Enlace a cita original
Passacquale G, Ferro A. Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events. BMJ 2011;342:1415-20. [Ref.ID 90956]
12.Tiene citas relacionadas
Cattaneo M. Prasugrel and cancer. Arch Intern Med 2010;170:1944. [Ref.ID 89705]
13.Tiene citas relacionadas
Goldstein MR, Mascitelli L, Pezzetta F. Platelet inhibition and cancer promotion. Arch Intern Med 2010;170:1943-4. [Ref.ID 89704]
14.Tiene citas relacionadas Cita con resumen
Floyd JS, Serebruany VL. Prasugrel as a potential cancer promoter: review of the unpublished data. Arch Intern Med 2010;170:1078-80. [Ref.ID 88851]
Eshaghian S, Amin S, Shah PK, Diamond GA. Role of clopidogrel in managing atherothrombotic cardiovascular disease. Ann Intern Med 2007;146:434-41. [Ref.ID 79711]
17.Tiene citas relacionadas Cita con resumen
Hallas J, Dall M, Andries A, Andersen BS, Aalykke C, Hansen JM, Andersen M, Lassen T. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006;333:726-8. [Ref.ID 78238]
18.Tiene citas relacionadas
Sung JJY. Combining aspirin with antithrombotic agents. BMJ 2006;333:712-3. [Ref.ID 78236]
19. Cita con resumen
Anónimo. Clopidogrel (Plavix) revisited. Med Lett Drugs Ther 2006;48:29-31. [Ref.ID 76844]
20.Tiene citas relacionadas
Bhatt DL, Hirsh J. The (variable) definition of benefit in the case of clopidogrel vs aspirin. In reply. Arch Intern Med 2005;165:1310-1. [Ref.ID 74483]
Seleccionar todas
 1 a 20 de 65 siguiente >>